194 related articles for article (PubMed ID: 24247297)
21. Inhibition of histamine receptor 3 suppresses glioblastoma tumor growth, invasion, and epithelial-to-mesenchymal transition.
Lin JJ; Zhao TZ; Cai WK; Yang YX; Sun C; Zhang Z; Xu YQ; Chang T; Li ZY
Oncotarget; 2015 Jul; 6(19):17107-20. PubMed ID: 25940798
[TBL] [Abstract][Full Text] [Related]
22. Icaritin inhibits the invasion and epithelial-to-mesenchymal transition of glioblastoma cells by targeting EMMPRIN via PTEN/AKt/HIF-1α signalling.
Xu B; Jiang C; Han H; Liu H; Tang M; Liu L; Ji W; Lu X; Yang X; Zhang Y; Liu Y
Clin Exp Pharmacol Physiol; 2015 Dec; 42(12):1296-307. PubMed ID: 26356761
[TBL] [Abstract][Full Text] [Related]
23. Antitumor efficacy of Lf modified daunorubicin plus honokiol liposomes in treatment of brain glioma.
Liu S; Zhang SM; Ju RJ; Xiao Y; Wang X; Song XL; Gu LY; Cheng L; Li XT; Chen GR
Eur J Pharm Sci; 2017 Aug; 106():185-197. PubMed ID: 28583810
[TBL] [Abstract][Full Text] [Related]
24. Honokiol crosses BBB and BCSFB, and inhibits brain tumor growth in rat 9L intracerebral gliosarcoma model and human U251 xenograft glioma model.
Wang X; Duan X; Yang G; Zhang X; Deng L; Zheng H; Deng C; Wen J; Wang N; Peng C; Zhao X; Wei Y; Chen L
PLoS One; 2011 Apr; 6(4):e18490. PubMed ID: 21559510
[TBL] [Abstract][Full Text] [Related]
25. Honokiol up-regulates prostacyclin synthease protein expression and inhibits endothelial cell apoptosis.
Zhang X; Chen S; Wang Y
Eur J Pharmacol; 2007 Jan; 554(1):1-7. PubMed ID: 17109844
[TBL] [Abstract][Full Text] [Related]
26. Honokiol induces paraptosis and apoptosis and exhibits schedule-dependent synergy in combination with imatinib in human leukemia cells.
Wang Y; Yang Z; Zhao X
Toxicol Mech Methods; 2010 Jun; 20(5):234-41. PubMed ID: 20374036
[TBL] [Abstract][Full Text] [Related]
27. Raddeanin A inhibited epithelial-mesenchymal transition (EMT) and angiogenesis in glioblastoma by downregulating β-catenin expression.
Wu B; Zhu J; Dai X; Ye L; Wang B; Cheng H; Wang W
Int J Med Sci; 2021; 18(7):1609-1617. PubMed ID: 33746577
[TBL] [Abstract][Full Text] [Related]
28. Major Contribution of Caspase-9 to Honokiol-Induced Apoptotic Insults to Human Drug-Resistant Glioblastoma Cells.
Wu GJ; Yang ST; Chen RM
Molecules; 2020 Mar; 25(6):. PubMed ID: 32210117
[TBL] [Abstract][Full Text] [Related]
29. H2-P, a honokiol derivative, exerts anti-angiogenesis effects via c-MYC signaling pathway in glioblastoma.
Wang T; Chen W; Wu J
J Cell Biochem; 2018 Apr; 119(4):3142-3148. PubMed ID: 29080353
[TBL] [Abstract][Full Text] [Related]
30. Honokiol induces a necrotic cell death through the mitochondrial permeability transition pore.
Li L; Han W; Gu Y; Qiu S; Lu Q; Jin J; Luo J; Hu X
Cancer Res; 2007 May; 67(10):4894-903. PubMed ID: 17510419
[TBL] [Abstract][Full Text] [Related]
31. Honokiol, a constituent of oriental medicinal herb magnolia officinalis, inhibits growth of PC-3 xenografts in vivo in association with apoptosis induction.
Hahm ER; Arlotti JA; Marynowski SW; Singh SV
Clin Cancer Res; 2008 Feb; 14(4):1248-57. PubMed ID: 18281560
[TBL] [Abstract][Full Text] [Related]
32. Nitidine chloride suppresses epithelial-mesenchymal transition and stem cell-like properties in glioblastoma by regulating JAK2/STAT3 signaling.
Jia M; Wang Y; Guo Y; Yu P; Sun Y; Song Y; Zhao L
Cancer Med; 2021 May; 10(9):3113-3128. PubMed ID: 33788424
[TBL] [Abstract][Full Text] [Related]
33. CD44 enhances the epithelial-mesenchymal transition in association with colon cancer invasion.
Cho SH; Park YS; Kim HJ; Kim CH; Lim SW; Huh JW; Lee JH; Kim HR
Int J Oncol; 2012 Jul; 41(1):211-8. PubMed ID: 22552741
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of glioblastoma angiogenesis and invasion by combined treatments directed against vascular endothelial growth factor receptor-2, epidermal growth factor receptor, and vascular endothelial-cadherin.
Lamszus K; Brockmann MA; Eckerich C; Bohlen P; May C; Mangold U; Fillbrandt R; Westphal M
Clin Cancer Res; 2005 Jul; 11(13):4934-40. PubMed ID: 16000592
[TBL] [Abstract][Full Text] [Related]
35. Polyphenol mixtures of Euphorbia supina the inhibit invasion and metastasis of highly metastatic breast cancer MDA-MB-231 cells.
Ko YS; Lee WS; Joo YN; Choi YH; Kim GS; Jung JM; Ryu CH; Shin SC; Kim HJ
Oncol Rep; 2015 Dec; 34(6):3035-42. PubMed ID: 26397047
[TBL] [Abstract][Full Text] [Related]
36. The Candidate Tumor Suppressor Gene SLC8A2 Inhibits Invasion, Angiogenesis and Growth of Glioblastoma.
Qu M; Yu J; Liu H; Ren Y; Ma C; Bu X; Lan Q
Mol Cells; 2017 Oct; 40(10):761-772. PubMed ID: 29047259
[TBL] [Abstract][Full Text] [Related]
37. Characterization of E-cadherin-dependent and -independent events in a new model of c-Fos-mediated epithelial-mesenchymal transition.
Mejlvang J; Kriajevska M; Berditchevski F; Bronstein I; Lukanidin EM; Pringle JH; Mellon JK; Tulchinsky EM
Exp Cell Res; 2007 Jan; 313(2):380-93. PubMed ID: 17141758
[TBL] [Abstract][Full Text] [Related]
38. Downregulation of uPA/uPAR inhibits intermittent hypoxia-induced epithelial-mesenchymal transition (EMT) in DAOY and D283 medulloblastoma cells.
Gupta R; Chetty C; Bhoopathi P; Lakka S; Mohanam S; Rao JS; Dinh DE
Int J Oncol; 2011 Mar; 38(3):733-44. PubMed ID: 21181094
[TBL] [Abstract][Full Text] [Related]
39. Down-regulating ribonuclease inhibitor enhances metastasis of bladder cancer cells through regulating epithelial-mesenchymal transition and ILK signaling pathway.
Xiong D; Liou Y; Shu J; Li D; Zhang L; Chen J
Exp Mol Pathol; 2014 Jun; 96(3):411-21. PubMed ID: 24768914
[TBL] [Abstract][Full Text] [Related]
40. AC1MMYR2, an inhibitor of dicer-mediated biogenesis of Oncomir miR-21, reverses epithelial-mesenchymal transition and suppresses tumor growth and progression.
Shi Z; Zhang J; Qian X; Han L; Zhang K; Chen L; Liu J; Ren Y; Yang M; Zhang A; Pu P; Kang C
Cancer Res; 2013 Sep; 73(17):5519-31. PubMed ID: 23811941
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
